UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
33.48
-0.27 (-0.80%)
At close: Oct 29, 2026, 4:00 PM EDT
32.55
-0.93 (-2.78%)
After-hours: Oct 29, 2026, 7:30 PM EDT
UroGen Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Reiterates $60 | Buy | Reiterates | $60 | +79.21% | Oct 28, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $58 | Buy | Maintains | $58 | +73.24% | Oct 20, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $75 | Buy | Reiterates | $75 | +124.01% | Oct 19, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $44 → $48 | Hold | Maintains | $44 → $48 | +43.37% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $50 → $60 | Buy | Reiterates | $50 → $60 | +79.21% | Aug 5, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $43 | Buy | Initiates | $43 | +28.43% | May 11, 2026 |